FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a haemostatic sponge based on one polymer of different viscosity. Disclosed haemostatic sponge is a two-layer spongy product containing sodium salt of carboxymethyl cellulose with average viscosity of 400–600 cP and sodium salt of carboxymethyl cellulose with high viscosity of 1,100–1,900 cP with weight fractions thereof in said article of 0.5 and 0.5.
EFFECT: invention provides shorter bleeding time and reduced blood loss.
1 cl, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE PREVENTION OF ADHESIONS DURING ABDOMINAL OPERATIONS UNDER CONDITIONS OF PARENCHYMAL BLEEDING IN AN EXPERIMENT | 2020 |
|
RU2744540C1 |
HEMOSTATIC POWDERS OF OXIDED REGENERATED CELLULOSE AND METHODS OF THEIR PRODUCTION | 2013 |
|
RU2629199C2 |
HAEMOSTATIC POWDERS OF OXIDISED REGENERATED CELLULOSE AND METHODS FOR PRODUCTION THEREOF | 2013 |
|
RU2696575C2 |
LOCAL HEMOSTATIC AGENT WITH ENHANCED ANTIMICROBIAL ACTIVITY | 2018 |
|
RU2675631C1 |
HAEMOSTATIC MEDICATION BASED ON SYNTHETIC TRIPEPTIDE PLASMIN INHIBITOR | 2014 |
|
RU2550945C1 |
METHOD OF SURGICAL TREATMENT OF PATIENTS WITH SEVERE LIVER INJURIES | 2017 |
|
RU2674874C1 |
METHOD FOR ASSESSING DYNAMICS OF THROMBOSIS WHEN USING HAEMOSTATIC AGENTS | 2023 |
|
RU2824478C1 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
SINGLE TOPICAL APPLICATION HEMOSTATIC GEL MANUFACTURING METHOD | 2022 |
|
RU2789581C1 |
HEMOSTATIC GEL FOR SINGLE TOPICAL APPLICATION | 2023 |
|
RU2796161C1 |
Authors
Dates
2024-02-20—Published
2023-04-25—Filed